Gray Foundation’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Gray Foundation's NBIX Position: Q3 2026 in Review
Gray Foundation held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 37,800 shares worth $5.36M. The position accounts for 1.25% of the portfolio, ranked #7.
Gray Foundation first reported a position in NBIX in Q4 2025 and has held it in 4 quarters since. The position peaked at $6.37M in Q2 2026. 772 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Gray Foundation held 37,800 shares of Neurocrine Biosciences worth $5.36M as of Q3 2026.
- Gray Foundation left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up 1.25% of Gray Foundation's portfolio in Q3 2026, its #7 holding.
- Gray Foundation first reported a position in Neurocrine Biosciences in Q4 2025 and has held it in 4 quarters since.
- Gray Foundation's Neurocrine Biosciences position peaked at $6.37M in Q2 2026.
- 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Gray Foundation's 13F filing for Q3 2026, filed 10 Nov 2026.